QuidelOrtho Completes Acquisition of LEX Diagnostics and Molecular Testing Platform
The $100 million deal brings an ultra-fast system for respiratory viruses to QuidelOrtho’s point-of-care portfolio.
The $100 million deal brings an ultra-fast system for respiratory viruses to QuidelOrtho’s point-of-care portfolio.
Using a molecule found in crustaceans, researchers developed a rapid approach that detects COVID comparably to one used in vaccine research.
The U.S. Food & Drug Administration (FDA) has granted 510(k) marketing clearance for this COVID-19 Antigen Home Test
A new survey found that clinical labs’ response to COVID helped to contain the virus and save lives, though new challenges have since arisen.
Read MoreAbbott’s ID NOW 2.0 point-of-care diagnostic testing platform received 510K clearance and CLIA waiver from the U.S. FDA.Â
Read MoreiHealth Labs, a provider of at-home COVID tests, announced its manufacturing facility for COVID tests manufactured over 70 million test kits.
Read MoreSensible Diagnostics was selected by the RADx Tech program launched by the NIBIB, which is part of the National Institutes of Health (NIH).
Read MoreRecent studies have highlighted the power of dogs in detecting COVID, even when obscured by other viruses, such as common colds and the flu.
Read MoreThe FDA granted 510(k) clearance to BD’s Respiratory Viral Panel for the BD MAX System, a diagnostic test that ID’s respiratory viruses.
Read MoreScientists developed a breath test that quickly identifies those who are infected with the virus that causes COVID.
Read MoreThe new biochip offers the potential to test multiple pathogens responsible for respiratory infections, such as COVID, RSV, and influenza.
Read MoreA team of RADx Tech and accessibility experts are actively working with the test manufacturer hopefuls to address the design of COVID tests.
Read MoreScripps Research scientists developed an AI application that can track the detailed evolution of epidemic viruses.
Read MoreScent dogs may represent a cheaper, faster, and more effective way to detect COVID-19, and could be a key tool in future pandemics.
Read MoreThe inexpensive real-time air monitor can detect any of the SARS-CoV-2 virus variants in a room in about 5 minutes, and could be used to detect influenza and RSV.
Read MoreAn Arkansas man was sentenced to 15 years in prison for conspiracy to commit healthcare fraud and money laundering through insurance claims for lab testing.
Read MoreWith the acquisition, Avacta gains Coris’ product portfolio including diagnostic tests for respiratory, gastro-enteric, and blood-borne pathogens and for the detection of antibiotic resistance markers.
Read MoreIn this episode of Clinical Lab Chat, Chris Wolski and his guest, medical lead at Hurdle, Alex Owens, MD, MPH, discuss the reasons for the rise of at-home testing during COVID, how at-home testing improves healthcare access, and the win-win-win it brings to clinical laboratories.
Read More